Condition: Malnutrition, Child · Malnutrition · Essential Fatty Acid Deficiency (EFAD) · Sponsor: Fresenius Kabi
Evaluate the risk of developing EFAD and/or PNAC in adult and pediatric patients 1 month of age and older, who are anticipated to need 8 weeks or longer of parenteral nutrition treatment with SMOFlipid.
This description comes directly from the study's public registry record.
Martin Stumpf, PhD · +49 6172 686 · martin.stumpf@fresenius-kabi.com
Jean-Marc Lohse, PhD · +49 6172 686 · Jean-Marc.Lohse@fresenius-kabi.com
Always discuss trial participation with your own doctor first.
| Emory University Hospital | Atlanta, Georgia, United States | Recruiting |
| The University of Chicago | Chicago, Illinois, United States | Not Yet Recruiting |
| Riley Hospital for Children | Indianapolis, Indiana, United States | Recruiting |
| Nationwide Children's Hospital | Columbus, Ohio, United States | Recruiting |
| Children's Hospital of Pittsburgh of UPMC | Pittsburgh, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06049680